Advertisement

Topics

The Melanoma Research Alliance Company Profile

16:04 EDT 20th September 2018 | BioPortfolio

MRA is a public charity formed in 2007 under the auspices of the Milken Institute, with the generous founding support of Debra and Leon Black. MRA is poised to build on recent momentum in the field, accelerating the pace of scientific discovery and translation in order to eliminate suffering and death due to melanoma. MRA’s ability to fund wide-ranging research in melanoma is amplified by unique multi-faceted collaborations and partnerships with individuals, private foundations and corporations. For more information, please visit www.curemelanoma.org.


News Articles [915 Associated News Articles listed on BioPortfolio]

Moffitt Cancer Center awarded $900,000 to study rare form of melanoma

(H. Lee Moffitt Cancer Center & Research Institute) A team of melanoma experts from Moffitt's Center of Excellence have been awarded a $900,000 three-year grant from the Melanoma Research Alliance to ...

Using virtual biopsies to improve melanoma detection

(Colorado State University) Jesse Wilson, an associate professor in the Department of Electrical and Computer Engineering and in the School of Biomedical Engineering, is one of 15 researchers selected...

Melanoma Research Alliance Announces New Funding Opportunity for Research to Accelerate Progress Toward Curing Melanoma

$9 Million in Funding for Melanoma Research including Special Opportunities in Artificial Intelligence, Dermatology, Immunotherapy & Radiation Oncology The Melanoma...

New Grants Totaling $2.6 Million Fund Work to Reduce Immunotherapy Side Effects

American Cancer Society and Melanoma Research Alliance Fund Five Innovative Approaches

New Alliance to Promote Vision of a Pan-Continental European Research Area

The John Innes Centre (JIC) in the United Kingdom has formed a new alliance with the Centre for Research in Agricultural Genomics in Spain, and the Max Planck Institute for Plant Breeding Research in ...

American Skin Association Announces 2018 Research Scholar Awards and Research Grants

The coveted ASA Milstein Research Scholar Award for Melanoma/Non-melanoma Skin Cancerhas been awarded to Carolyn Lee, MD, PhDfrom Stanford Universityfor her Read more...

TGen-led canine melanoma study identifies genetic basis of disease; potential drug targets

(The Translational Genomics Research Institute) TGen and its collaborators from across the nation used multiple genomic analysis techniques to identify several gene mutations that could be the keys to...

MRA Applauds Latest Melanoma Drug Approval

New targeted therapy combination offers patients additional choice The Melanoma Research Alliance (MRA) today welcomed news that the U.S. Food & Drug Administration (FDA) ...

PubMed Articles [1331 Associated PubMed Articles listed on BioPortfolio]

The Development of the Working Alliance and Its Ability to Predict Outcome in Emotion-Focused Therapy for Social Anxiety Disorder.

The study focuses on the alliance of 12 patients receiving emotion-focused therapy for social anxiety. Anxiety symptoms and patient perception of the working alliance were examined weekly. The first e...

The alliance in adult psychotherapy: A meta-analytic synthesis.

The alliance continues to be one of the most investigated variables related to success in psychotherapy irrespective of theoretical orientation. We define and illustrate the alliance (also conceptuali...

Development of the Working Alliance Inventory-Short Form Japanese version through factor analysis and test-retest reliability.

Working alliance between the physiotherapist and patient is important for successful treatment in physiotherapy. Working alliance can be measured by a 12-item self-reporting measure with 7-point Liker...

Melanoma in US Hispanics: recommended strategies to reduce disparities in outcomes.

Cutaneous melanoma is the most fatal form of skin cancer and presents a considerable public health concern in the United States. Although the age-adjusted incidence of melanoma among US Hispanics is l...

Fulminant type 1 diabetes associated with nivolumab in a patient with metastatic melanoma.

Clinical Trials [2321 Associated Clinical Trials listed on BioPortfolio]

Construction of the Therapeutic Alliance Between Inpatient Psychiatric Patients and Nurses

Clarify the determinants of the construction of a Therapeutic Alliance (AT) between paramedical staff (nurses and caregivers ) and adult patients in a functional unit of full-time general ...

Therapeutic Alliance Tensions and Repair in Psychotherapy Practices

This study evaluates a professional development program intended to improve the relationship or alliance between therapists and patients/clients who are receiving psychotherapy in the comm...

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

The purpose of this study is to examine the health behaviors of melanoma survivors. We want to know about their thoughts and concerns. Melanoma is a type of skin cancer. The number of peop...

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

This is a research study to look at the ways in which a treatment called INGN241 can kill melanoma cells or help the patient's immune system kill melanoma cells.

A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma

The purpose of this research study is to find out whether JX-594 is safe and effective for treating surgically unresectable malignant melanoma.

Companies [1594 Associated Companies listed on BioPortfolio]

AIM at Melanoma

AIM at Melanoma, founded in memory of Charlie Guild, who died of melanoma at the age of 26, is the largest international melanoma foundation focused on melanoma research, patient ...

Melanoma Research Alliance (MRA)

MRA is a public charity formed in 2007 under the auspices of the Milken Institute, with the generous founding support of Debra and Leon Black. Due to the ongoing support of its fo...

The Melanoma Research Alliance

MRA is a public charity formed in 2007 under the auspices of the Milken Institute, with the generous founding support of Debra and Leon Black. MRA is poised to build on recent mom...

Melanoma Research Alliance

MRA is a public charity formed in 2007 under the auspices of the Milken Institute, with the generous founding support of Debra and Leon Black. MRA is poised to build on recent mom...

Polynoma LLC

Malignant melanoma is the most serious form of skin cancer. An estimated 200,000 new cases of melanoma are diagnosed annually around the world, with about 76,000 in the United Sta...

More Information about "The Melanoma Research Alliance" on BioPortfolio

We have published hundreds of The Melanoma Research Alliance news stories on BioPortfolio along with dozens of The Melanoma Research Alliance Clinical Trials and PubMed Articles about The Melanoma Research Alliance for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Melanoma Research Alliance Companies in our database. You can also find out about relevant The Melanoma Research Alliance Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Melanoma
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record